Linc00839 promotes malignancy of liver cancer via binding fmnl2 under hypoxia

HIGHLIGHTS

• who: Yangyi Xie from the Guangxi University ofNanning, China have published the paper: LINC00839 promotes malignancy of liver cancer via binding FMNL2 under hypoxia, in the Journal: Scientific Reports Scientific Reports
• what: The authors investigated the contribution of lncRNA in hypoxia promoting liver cancer progression.
• how: The results showed that its expression levels in liver cancer cell lines were approximately three to eightfold higher than that in normal liver cell line (Fig 2C). Mass spectrometry (MS) was used to analyzed the proteins pulled down by LINC00839 and the results were available via ProteomeXchange . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.